Hypokalemia, Diabetes Mellitus, and Hypercortisolemia are the Major Contributing Factors to Cardiac Dysfunction in Adrenal Cushing's Syndrome-Reference-Cited by-同舟云学术

Hypokalemia, Diabetes Mellitus, and Hypercortisolemia are the Major Contributing Factors to Cardiac Dysfunction in Adrenal Cushing's Syndrome

Published:2009 Issue:8 Volume:56 Page:1009-1018
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

TAKAGI Sachiko¹,TANABE Akiyo¹,TSUIKI Mika¹,NARUSE Mitsuhide²,TAKANO Kazue¹

Affiliation:

1. Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women’s Medical University, Tokyo, Japan

2. Clinical Research Institute, Division of Endocrinology, Metabolism and Hypertension, Kyoto Medical Center, National Hospital Organization, Kyoto, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/56/8/56_K09E-198/_pdf

Reference45 articles.

1. The natural history of treated Cushing's syndrome

2. 2. Welbourn RB (1985) Survival and causes of after adrenalectomy for Cushing’s disease. Surgery 97: 16-20.

3. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines

4. Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing’s Disease during Active Disease and 1 Year after Disease Remission

5. Persistence of Increased Cardiovascular Risk in Patients with Cushing's Disease after Five Years of Successful Cure

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Cardiac QT Interval;Endocrine Practice;2024-01

2. Hydrosaline Alterations in Cushing Disease;Endocrinology;2023

3. Hydrosaline Alterations in Cushing Disease;Endocrinology;2023

4. Cardiac Hypertrophy and Related Dysfunctions in Cushing Syndrome Patients—Literature Review;Journal of Clinical Medicine;2022-11-28

5. Medical therapy in severe hypercortisolism;Best Practice & Research Clinical Endocrinology & Metabolism;2021-03